Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data

Neoplasia - Tập 22 - Trang 820-830 - 2020
Angela M. Jarrett1,2, David A. Hormuth1,2, Chengyue Wu3, Anum S. Kazerouni3, David A. Ekrut1, John Virostko2,4,5, Anna G. Sorace6,7,8, Julie C. DiCarlo1, Jeanne Kowalski2,5, Debra Patt9, Boone Goodgame5,10,11, Sarah Avery12, Thomas E. Yankeelov1,2,3,4,5,13
1Oden Institute for Computational Engineering and Sciences, Austin, TX, USA
2Livestrong Cancer Institutes, Austin, TX, USA
3Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA
4Department of Diagnostic Medicine, The University of Texas at Austin, Austin, TX, USA
5Department of Oncology, The University of Texas at Austin, Austin, TX, USA
6Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA
7Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA
8O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
9Texas Oncology, Austin, TX, USA
10Department of Internal Medicine, The University of Texas at Austin, Austin, TX, USA
11Seton Hospital, Austin, TX, USA
12Austin Radiological Association, Austin, TX, USA
13Department of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA

Tài liệu tham khảo

Arnaout, 2018, Neoadjuvant therapy for breast cancer:updates and proceedings from the seventh annual meeting of the canadian consortium for locally advanced breast cancer, Curr Oncol, 25, e490, 10.3747/co.25.4153 Thompson, 2012, Neoadjuvant treatment of breast cancer, Ann Oncol, 23, x231, 10.1093/annonc/mds324 Pinkel, 1958, The use of body surface area as a criterion of drug dosage in cancer chemotherapy, Cancer Res, 18, 853 Dunnwald, 2007, Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients, Breast Cancer Res, 9, R6, 10.1186/bcr1639 Yang, 2018, Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy, World J Surg Oncol, 16, 51, 10.1186/s12957-018-1332-7 Olopade, 2008, Advances in breast cancer: pathways to personalized medicine, Clin Cancer Res, 14, 7988, 10.1158/1078-0432.CCR-08-1211 Ludwig, 2005, Biomarkers in cancer staging, prognosis and treatment selection, Nat Rev Cancer, 5, 845, 10.1038/nrc1739 Chen, 2013, Kidney tumor growth prediction by coupling reaction-diffusion and biomechanical model, IEEE Trans Biomed Eng, 60, 169, 10.1109/TBME.2012.2222027 Hormuth, 2019, Mechanism-based modeling of tumor growth and treatment response constrained by multiparametric imaging data, Jco Clin Cancer Inform, 10 Swan, 2017, A patient-specific anisotropic diffusion model for brain tumour spread, Bull Math Biol, 80, 1259, 10.1007/s11538-017-0271-8 Roque, 2018, A DCE-MRI driven 3-D reaction-diffusion model of solid tumor growth, IEEE Trans Med Imaging, 37, 724, 10.1109/TMI.2017.2779811 Le, 2016, MRI based bayesian personalization of a tumor growth model, IEEE Trans Med Imaging, 35, 2329, 10.1109/TMI.2016.2561098 Yankeelov, 2013, Clinically relevant modeling of tumor growth and treatment response, Sci Transl Med, 5, 10.1126/scitranslmed.3005686 Rockne, 2010, Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach, Phys Med Biol, 55, 3271, 10.1088/0031-9155/55/12/001 Clatz, 2005, Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation, IEEE Trans Med Imaging, 24, 1334, 10.1109/TMI.2005.857217 Baldock, 2013, From patient-specific mathematical neuro-oncology to precision medicine, Front Oncol, 3, 62, 10.3389/fonc.2013.00062 Mi, 2014, Prediction of lung tumor evolution during radiotherapy in individual patients with PET, IEEE Trans Med Imaging, 33, 995, 10.1109/TMI.2014.2301892 Mi, 2015, Joint tumor growth prediction and tumor segmentation on therapeutic follow-up PET images, Med Image Anal, 23, 84, 10.1016/j.media.2015.04.016 Liu, 2014, Patient specific tumor growth prediction using multimodal images, Med Image Anal, 18, 555, 10.1016/j.media.2014.02.005 Wong, 2015, Tumor growth prediction with reaction-diffusion and hyperelastic biomechanical model by physiological data fusion, Med Image Anal, 25, 72, 10.1016/j.media.2015.04.002 Weis, 2013, A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy, Phys Med Biol, 58, 5851, 10.1088/0031-9155/58/17/5851 Weis, 2015, Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled reaction-diffusion model, Cancer Res, 75, 4697, 10.1158/0008-5472.CAN-14-2945 Weis, 2017, Three-dimensional image-based mechanical modeling for predicting the response of breast cancer to neoadjuvant therapy, Comput Methods Appl Mech Eng, 314, 494, 10.1016/j.cma.2016.08.024 Atuegwu, 2013, Parameterizing the logistic model of tumor growth by DW-MRI and DCE-MRI data to predict treatment response and changes in breast cancer cellularity during neoadjuvant chemotherapy, Transl Oncol, 6, 256, 10.1593/tlo.13130 Jarrett, 2018, Incorporating drug delivery into an imaging-driven, mechanics-coupled reaction diffusion model for predicting the response of breast cancer to neoadjuvant chemotherapy: theory and preliminary clinical results, Phys Med Biol, 63, 10.1088/1361-6560/aac040 Copur, 2016, Impact of the national cancer institute community cancer centers program on clinical trial and related activities at a community cancer center in rural nebraska, J Oncol Pract, 12, 67, 10.1200/JOP.2015.005736 Sorace, 2018, Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting, J Magn Reson Imaging, 10.1002/jmri.26011 Virostko, 2019, Magnetization transfer MRI of breast cancer in the community setting: reproducibility and preliminary results in neoadjuvant therapy, Tomography, 5, 44, 10.18383/j.tom.2018.00019 Whisenant, 2014, Assessing reproducibility of diffusion-weighted magnetic resonance imaging studies in a murine model of HER2+ breast cancer, Magn Reson Imaging, 32, 245, 10.1016/j.mri.2013.10.013 Yankeelov, 2007, Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples, Current Medical Imaging Reviews, 3, 91, 10.2174/157340507780619179 Atuegwu, 2011, Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy, Magn Reson Med, 66, 1689, 10.1002/mrm.23203 Atuegwu, 2012, Incorporation of diffusion-weighted magnetic resonance imaging data into a simple mathematical model of tumor growth, Phys Med Biol, 57, 225, 10.1088/0031-9155/57/1/225 Eisenhauer, 2009, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, 45, 228, 10.1016/j.ejca.2008.10.026 Hormuth, 2015, Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data, Phys Biol, 12, 10.1088/1478-3975/12/4/046006 Hormuth, 2017, A mechanically coupled reaction-diffusion model that incorporates intra-tumoural heterogeneity to predict in vivo glioma growth, J R Soc Interface, 14, 10.1098/rsif.2016.1010 Hormuth, 2018, Mechanically coupled reaction-diffusion model to predict glioma growth: methodological details, Methods Mol Biol, 1711, 225, 10.1007/978-1-4939-7493-1_11 Hormuth, 2018, Biophysical modeling of in vivo glioma response following whole brain radiotherapy in a murine model of brain cancer, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2017.12.004 Hormuth, 2019, Calibrating a predictive model of tumor growth and angiogenesis with quantitative MRI, Ann Biomed Eng, 47, 1539, 10.1007/s10439-019-02262-9 Barpe, 2010, Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass, Eur J Pharm Sci, 41, 458, 10.1016/j.ejps.2010.07.015 van der Vijgh, 1991, Clinical pharmacokinetics of carboplatin, Clin Pharmacokinet, 21, 242, 10.2165/00003088-199121040-00002 Mori, 2006, Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro, Cancer Chemother Pharmacol, 58, 665, 10.1007/s00280-006-0209-6 Tew, 2016, Paclitaxel, Ref Module Biomed Sci, 10.1016/B978-0-12-801238-3.99393-0 Yang, 2015, Pharmacokinetics and safety of cyclophosphamide and docetaxel in a hemodialysis patient with early stage breast cancer: a case report, BMC Cancer, 15, 917, 10.1186/s12885-015-1932-3 Powis, 1987, Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients, Cancer Chemother Pharmacol, 20, 219, 10.1007/BF00570489 Bruynseels, 2018, Digital twins in health care: ethical implications of an emerging engineering paradigm, Front Genet, 9, 31, 10.3389/fgene.2018.00031 Efron, 1993, An Introduction to the Bootstrap, 57 Coveney, 2016, Big data need big theory too, Philos Trans A Math Phys Eng Sci, 374 Hormuth, 2020, Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling, Radiat Oncol, 15, 4, 10.1186/s13014-019-1446-2 Jarrett, 2020, Abstract P2-16-17: Optimizing neoadjuvant regimens for individual breast cancer patients generated by a mathematical model utilizing quantitative magnetic resonance imaging data: Preliminary results, Cancer Res, 80